PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
作者信息
Qamar Iqra, Grewal Simran, Fahed Akl C, Weiner Rory, Tawakol Ahmed, Osborne Michael T
机构信息
Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
出版信息
J Nucl Cardiol. 2023 Oct;30(5):2187-2190. doi: 10.1007/s12350-023-03337-w. Epub 2023 Jul 19.
Abstract
摘要
相似文献
1
PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
J Nucl Cardiol. 2023 Oct;30(5):2187-2190. doi: 10.1007/s12350-023-03337-w. Epub 2023 Jul 19.
2
Regadenoson: a focused update.
J Nucl Cardiol. 2013 Apr;20(2):284-8. doi: 10.1007/s12350-012-9661-3.
3
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
J Nucl Cardiol. 2017 Feb;24(1):112-118. doi: 10.1007/s12350-015-0303-4. Epub 2015 Nov 18.
4
A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
J Nucl Cardiol. 2013 Apr;20(2):185-96. doi: 10.1007/s12350-012-9641-7. Epub 2012 Nov 28.
5
Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
J Cardiovasc Comput Tomogr. 2014 Jan-Feb;8(1):2-12. doi: 10.1016/j.jcct.2013.09.004. Epub 2013 Oct 18.
6
Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
J Nucl Cardiol. 2012 Aug;19(4):727-34. doi: 10.1007/s12350-012-9559-0. Epub 2012 Apr 24.
7
Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
J Nucl Cardiol. 2020 Dec;27(6):2320-2331. doi: 10.1007/s12350-019-01661-8. Epub 2019 Feb 27.
8
Off-label, but on-target: use of regadenoson with exercise.
J Nucl Cardiol. 2013 Apr;20(2):179-81. doi: 10.1007/s12350-012-9643-5.
9
Outcome of patients with regadenoson-induced ST-segment depression but normal perfusion on single-photon emission computed tomography.
Angiology. 2013 Jan;64(1):46-8. doi: 10.1177/0003319711436073. Epub 2012 Feb 8.
10
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
J Nucl Cardiol. 2015 Apr;22(2):248-61. doi: 10.1007/s12350-014-9981-6. Epub 2014 Oct 7.
本文引用的文献
1
Inferior Myocardial Infarction Secondary to Coronary Artery Vasospasm Following Regadenoson Stress Imaging.
J Med Cases. 2022 Jan;13(1):11-14. doi: 10.14740/jmc3850. Epub 2022 Jan 17.
2
Vasospastic angina: A literature review of current evidence.
Arch Cardiovasc Dis. 2019 Jan;112(1):44-55. doi: 10.1016/j.acvd.2018.08.002. Epub 2018 Sep 7.
3
Regadenoson-induced coronary vasospasm resulting in severe reversible perfusion defects and transient ischemic dilation on SPECT stress myocardial perfusion imaging.
J Nucl Cardiol. 2016 Aug;23(4):843-5. doi: 10.1007/s12350-015-0275-4. Epub 2015 Sep 18.
Zotero 插件